| Literature DB >> 17459161 |
Jennifer L Ingram1, Aurita Antao-Menezes, Elizabeth A Turpin, Duncan G Wallace, James B Mangum, Linda J Pluta, Russell S Thomas, James C Bonner.
Abstract
BACKGROUND: Exposure to vanadium pentoxide (V2O5) is a cause of occupational bronchitis. We evaluated gene expression profiles in cultured human lung fibroblasts exposed to V2O5 in vitro in order to identify candidate genes that could play a role in inflammation, fibrosis, and repair during the pathogenesis of V2O5-induced bronchitis.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17459161 PMCID: PMC1865536 DOI: 10.1186/1465-9921-8-34
Source DB: PubMed Journal: Respir Res ISSN: 1465-9921
Figure 1Heatmap showing hierarchical clustering of human lung fibroblast genes significantly induced (RED) or suppressed (GREEN) by V2O5 treatment. Gene expression in response to V2O5 was considered significant if p-value ≤ 0.05 and exhibited ≥ 2-fold change over untreated control. Left panel: All genes changed more than 2-fold. Panels A and B: Representative clusters of genes progressively induced. Panel C: Representative cluster of genes induced in a biphasic manner. Panel D: Representative cluster of suppressed genes. Panel E: Representative clusters of genes induced early then suppressed late.
Figure 2Gene expression profiles of selected genes of interest that fit one of four different temporal expression categories. Fold changes in gene expression over the time course of the experiment are shown on a log2 scale. A) Progressively induced genes, B) Progressively suppressed genes, C) Genes induced early and suppressed late, and D) Genes induced in a biphasic manner. The cellular localization and function of each of these genes are shown in Table 1.
Temporal expression categories of selected genes significantly induced or suppressed by V2O5 exposure and their cellular localization and functions (See Fig. 2).
| Hs.25590 | Stanniocalcin | Secreted | Cellular Metabolism | |
| Hs.448611 | Pre-B Cell Colony Enhancing Factor 1 | Secreted | Inflammation | |
| Hs.78913 | Chemokine (C-X3-C motif) Receptor 1 | Membrane | Inflammation | |
| Hs.515258 | Growth and Differentiation Factor-15 | Secreted | Growth Inhibition | |
| Hs.471221 | Kruppel-like factor 7 | Nuclear | Transcriptional Regulation | |
| Hs.525704 | V-jun sarcoma virus 17 oncogene | Nuclear | Transcriptional Regulation | |
| Hs.65029 | Growth Arrest Specific Gene 1 | Nuclear | Growth Arrest and Apoptosis | |
| Hs.519162 | B-Cell Translocation Gene 2 | Nuclear | Growth Arrest | |
| Hs.255935 | B-Cell Translocation Gene 1 | Nuclear | Growth Arrest | |
| Hs.8375 | TNF Receptor-Associated Factor | Membrane | Inflammation/Immunity | |
| Hs. 109225 | Vascular Cell Adhesion Molecule 1 | Membrane | Cell Adhesion | |
| Hs.519909 | Myristolated Alanine-rich C Kinase Substrate | Cytoplasmic | Cell Signaling | |
| Hs.298654 | MAP kinase phosphatase 3 | Cytoplasmic | Cell Signaling | |
| Hs.532411 | Lysosomal Trafficking Regulator Gene | Cytoplasmic | Cell Signaling | |
| Hs.514746 | GATA6 Transcription Factor | Nuclear | Transcriptional Regulation | |
| Hs.37982 | Neural expressed Develop. down-regulated 9 | Membrane | Cell Adhesion | |
| Hs.502328 | CD44 molecule (Indian blood group) | Membrane | Cell Signaling | |
| Hs.59332 | Sprouty-Related EVH Domain-2 | Cytoplasmic | Cell Signaling | |
| Hs.326035 | Early Growth Response-1 Gene | Cytoplasmic/Nuclear | Transcriptional Regulation | |
| Hs.534313 | Early Growth Response-3 Gene | Cytoplasmic/Nuclear | Transcriptional Regulation | |
| Hs.73853 | Bone Morphogenic Protein-1 | Secreted | Cell Differentiation | |
| Hs.591241 | Cyclin T2 | Nuclear | Cell Cycle Regulation | |
| Hs.62661 | guanylate-binding protein 1, IFN-inducible | Cytoplasmic | Antiviral Activitiy | |
| Hs.419240 | Solute Carrier Family 2 (GLUT3) | Membrane | Metabolism | |
aGene annotat ions are from NCBI .
Functional analysis of genes induced or suppressed by V2O5 in human lung fibroblasts.a
| 0009605 | response to external stimulus | 32 | 8.47 | 1.43E-05 |
| 0006935 | chemotaxis | 13 | 3.44 | 6.96E-05 |
| 0009611 | response to wounding | 25 | 6.61 | 1.81E-04 |
| 0042221 | response to chemical stimulus | 23 | 6.08 | 2.51 E-04 |
| 0006950 | response to stress | 44 | 11.64 | 0.003553 |
| 0006928 | cell motility | 15 | 3.97 | 0.005005 |
| 0006396 | RNA processing | 19 | 5.03 | 0.005027 |
| 0008380 | RNA splicing | 11 | 2.91 | 0.007903 |
| 0006954 | inflammatory response | 13 | 3.44 | 0.011869 |
| 0008284 | positive regulation of cell proliferation | 10 | 2.65 | 0.013783 |
| 0006955 | immune response | 33 | 8.73 | 0.018616 |
| 0007267 | cell-cell signaling | 23 | 6.08 | 0.042107 |
| 0045449 | regulation of transcription | 298 | 19.34 | 3.61 E-25 |
| 0006512 | ubiquitin cycle | 81 | 5.26 | 1.16E-10 |
| 0006391 | RNA processing | 72 | 4.67 | 6.25E-10 |
| 0007049 | cell cycle | 113 | 7.33 | 4.42E-08 |
| 0006974 | response to DNA damage stimulus | 52 | 3.37 | 1.13E-07 |
| 0006295 | DNA metabolism | 94 | 6.10 | 2.23E-06 |
| 0006281 | DNA repair | 43 | 2.79 | 1.23E-05 |
| 0008380 | RNA splicing | 33 | 2.14 | 2.56E-05 |
| 0007243 | protein kinase cascade | 50 | 3.24 | 3.39E-05 |
| 0051301 | cell division | 31 | 2.01 | 2.71 E-04 |
| 0051169 | nuclear transport | 23 | 1.49 | 6.27E-04 |
| 0016310 | phosphorylation | 88 | 5.71 | 8.76E-04 |
| 0019538 | protein metabolism | 311 | 20.18 | 0.001149 |
| 0030518 | steroid hormone receptor signaling pathway | 13 | 0.84 | 0.001328 |
| 0050658 | RNA transport | 12 | 0.78 | 0.002917 |
| 0012501 | programmed cell death | 76 | 4.93 | 0.003907 |
| 0001558 | regulation of cell growth | 22 | 1.43 | 0.004779 |
| 0016568 | chromatin modification | 22 | 1.43 | 0.005351 |
| 0007259 | JAK-STAT cascade | 9 | 0.58 | 0.008321 |
| 0007050 | cell cycle arrest | 14 | 0.91 | 0.013090 |
| 0016055 | Wnt receptor signaling pathway | 18 | 1.17 | 0.020398 |
| 0015031 | protein transport | 65 | 4.22 | 0.034144 |
| 0008286 | insulin receptor signaling pathway | 6 | 0.39 | 0.039295 |
| 0007249 | l-kappaB kinase/NF-kappaB cascade | 18 | 1.17 | 0.042224 |
a GO analysis performed using NIH DAVID .
b Gene ontology ID numbers obtained from AmiGO .
c% of total induced or suppressed genes.
Figure 3Gene expression profiles of selected genes for six functional categories. Fold changes in gene expression over the time course of the experiment are shown on a log2 scale. A) Cytokines and Chemokines, B) Growth Factors, C) STAT Signaling, D) Cell Cycle Regulation, E) Oxidative Stress, and F) TGF-β Signaling. The cellular localization and function of each of these genes are shown in Table 3.
Cellular localization and functions of genes regulated by V2O5 grouped by functional categories (See Fig. 3).
| Hs.512234 | lnterleukin-6 (interferon beta2) | Secreted | Inflammation | |
| Hs.624 | lnterleukin-8 | Secreted | Neutrophil Chemotaxis | |
| Hs. 168132 | lnterleukin-15 | Secreted | T Lymphocyte Proliferation | |
| Hs.271387 | CC Chemokine Ligand 8 | Secreted | Neutrophil Chemotaxis | |
| Hs.77367 | Chemokine (C-X-C motif) Ligand 9 (Mig) | Secreted | Inflammation | |
| Hs.632586 | Chemokine (C-X-C motif) Ligand 10 (IP-10) | Secreted | Inflammation | |
| Hs.73793 | Vascular Endothelial Cell Growth Factor | Secreted | Endothelial Cell Growth | |
| Hs.396530 | Hepatocyte Growth Factor | Secreted | Epithelial Cell Growth | |
| Hs.799 | Heparin-Binding EGF-like Growth Factor | Membrane/Secreted | Fibroblast Growth | |
| Hs.591346 | Connective Tissue Growth Factor | Secreted | Collagen Synthesis | |
| Hs.111 | Fibroblast Growth Factor-9 | Membrane/Secreted | Fibroblast Growth | |
| Hs.284244 | Fibroblast Growth Factor-2 | Membrane/Secreted | Fibroblast Growth | |
| Hs.591081 | Janus Activated Kinase-2 | Membrane | STAT Phosphorylation | |
| Hs.436061 | Interferon-Regulatory Factor-1 | Cytoplasmic/Nuclear | Transcriptional Regulation | |
| Hs.527973 | Suppressor of Cytokine Signaling-3 | Cytoplasmic | Cell Signaling | |
| Hs.50640 | Suppressor of Cytokine Signaling-1 | Cytoplasmic | Cell Signaling | |
| Hs.470943 | Signal Transducer Activator of Transcription | Cytoplasmic | Growth Arrest and Apoptosis | |
| Hs.520414 | Interferon Gamma Receptor- 1 | Membrane | Cell Signaling | |
| Hs.238990 | Cyclin-Dependent Kinase lnhbitior-1B (Kip1) | Nuclear | Cell Cycle Arrest | |
| Hs. 106070 | Cyclin-Dependent Kinase lnhibitor-1C (Kip2) | Nuclear | Cell Cycle Arrest | |
| Hs.525324 | Cyclin-Dependent Kinase lnhibitor-2C | Nuclear | Cell Cycle Arrest | |
| Hs.557646 | Cyclin-Dependent Kinase-9 | Nuclear | Transcriptional Regulation | |
| Hs. 184298 | Cyclin-Dependent Kinase-7 | Nuclear | Transcriptional Regulation | |
| Hs. 13291 | Cyclin G2 | Nuclear | Cell Cycle Arrest | |
| Hs.475970 | Oxidative Stress Response 1 | Cytoplasmic | Intracellular Kinase | |
| Hs.487046 | Superoxide Dismutase 2 (SOD2) | Cytoplasmic | Peroxide Generation | |
| Hs. 148778 | Oxidative Resistance 1 | Cytoplasmic | Anti-Oxidant | |
| Hs.462585 | Pipecolic Acid Oxidase | Cytoplasmic | Peroxide Generation | |
| Hs.465870 | Kelch-like ECH-associated protein 1 | Cytoplasmic | Redox Homeostasis | |
| Hs.406515 | NAD(P)H:quinone oxidoreductase 1 | Cytoplasmic | Redox Homeostasis | |
| Hs. 133379 | Transforming Growth Factor beta-2 | Secreted | Matrix Synthesis, Immunity | |
| Hs.519005 | mothers against DPP homolog 1 | Cytoplasmic | Cell Signaling | |
| Hs. 189329 | Smad Ubiquitin Regulatory Factor-1 | Cytoplasmic | Cell Signaling | |
| Hs.489142 | Collagen 1A2 | Secreted | Structural Protein | |
| Hs. 172928 | Collagen 1A1 | Secreted | Structural Protein | |
| Hs.443625 | Collagen 3A1 | Secreted | Structural Protein | |
aGene annotations are from NCBI .
Figure 4Validation of selected genes by Taqman quantitative RT-PCR. RNA was isolated from human lung fibroblasts treated with 10 μg/cm2 V2O5 at the indicated time points and RT-PCR performed as described in Methods. Three genes from four categories were validated; growth factors (top row: VEGF, HBEGF, CTGF), chemokines (second row: IL8, CXCL9, CXCL10), transcription factors (third row: Egr1, STAT1, GAS1), and oxidative stress genes (bottom row: PIPOX, OXR1, SOD2). The data for each gene was normalized against 18S housekeeping gene and expressed as the mean ratio. Data are representative of at least two replicate experiments and expressed as the mean ± sem of triplicate dishes of cells. The temporal pattern of each V2O5-altered gene validated by RT-PCR is compared with the result obtained from the microarray experiment (open diamonds).
Figure 5Illustration showing postulated roles of selected V2O5-induced or -suppressed genes in the context of upstream cell signaling events and downstream cell responses and pathologic consequences. All genes shown were validated by quantitative RT-PCR (see Fig. 4).